GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Blum Holdings Inc (OTCPK:BLMH) » Definitions » Piotroski F-Score

Blum Holdings (Blum Holdings) Piotroski F-Score : 4 (As of May. 18, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Blum Holdings Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Blum Holdings has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Blum Holdings's Piotroski F-Score or its related term are showing as below:

BLMH' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 4   Max: 5
Current: 4

During the past 13 years, the highest Piotroski F-Score of Blum Holdings was 5. The lowest was 2. And the median was 4.


Blum Holdings Piotroski F-Score Historical Data

The historical data trend for Blum Holdings's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blum Holdings Piotroski F-Score Chart

Blum Holdings Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 4.00 3.00 2.00 3.00

Blum Holdings Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 3.00 2.00 3.00 4.00

Competitive Comparison of Blum Holdings's Piotroski F-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Blum Holdings's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Blum Holdings's Piotroski F-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Blum Holdings's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Blum Holdings's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep23) TTM:Last Year (Sep22) TTM:
Net Income was 3.567 + 0.41 + -1.442 + -3.362 = $-0.83 Mil.
Cash Flow from Operations was -0.806 + -2.275 + 0.13 + 1.594 = $-1.36 Mil.
Revenue was 7.644 + 8.729 + 8.797 + 8.612 = $33.78 Mil.
Gross Profit was 2.739 + 4.184 + 4.6 + 3.994 = $15.52 Mil.
Average Total Assets from the begining of this year (Sep22)
to the end of this year (Sep23) was
(53.849 + 40.508 + 39.466 + 38.26 + 36.531) / 5 = $41.7228 Mil.
Total Assets at the begining of this year (Sep22) was $53.85 Mil.
Long-Term Debt & Capital Lease Obligation was $14.27 Mil.
Total Current Assets was $7.05 Mil.
Total Current Liabilities was $59.04 Mil.
Net Income was -9.741 + -8.873 + -63.718 + -119.906 = $-202.24 Mil.

Revenue was 17.14 + 18.445 + 15.801 + 9.721 = $61.11 Mil.
Gross Profit was 7.776 + 5.709 + 8.087 + -0.042 = $21.53 Mil.
Average Total Assets from the begining of last year (Sep21)
to the end of last year (Sep22) was
(259.321 + 271.824 + 249.802 + 180.255 + 53.849) / 5 = $203.0102 Mil.
Total Assets at the begining of last year (Sep21) was $259.32 Mil.
Long-Term Debt & Capital Lease Obligation was $20.07 Mil.
Total Current Assets was $7.21 Mil.
Total Current Liabilities was $74.54 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Blum Holdings's current Net Income (TTM) was -0.83. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Blum Holdings's current Cash Flow from Operations (TTM) was -1.36. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Sep22)
=-0.827/53.849
=-0.01535776

ROA (Last Year)=Net Income/Total Assets (Sep21)
=-202.238/259.321
=-0.77987514

Blum Holdings's return on assets of this year was -0.01535776. Blum Holdings's return on assets of last year was -0.77987514. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Blum Holdings's current Net Income (TTM) was -0.83. Blum Holdings's current Cash Flow from Operations (TTM) was -1.36. ==> -1.36 <= -0.83 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep22 to Sep23
=14.273/41.7228
=0.34209113

Gearing (Last Year: Sep22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep21 to Sep22
=20.065/203.0102
=0.0988374

Blum Holdings's gearing of this year was 0.34209113. Blum Holdings's gearing of last year was 0.0988374. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Sep23)=Total Current Assets/Total Current Liabilities
=7.049/59.037
=0.1193997

Current Ratio (Last Year: Sep22)=Total Current Assets/Total Current Liabilities
=7.208/74.538
=0.09670235

Blum Holdings's current ratio of this year was 0.1193997. Blum Holdings's current ratio of last year was 0.09670235. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Blum Holdings's number of shares in issue this year was 9.665. Blum Holdings's number of shares in issue last year was 5.799. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=15.517/33.782
=0.45932745

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=21.53/61.107
=0.35233279

Blum Holdings's gross margin of this year was 0.45932745. Blum Holdings's gross margin of last year was 0.35233279. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Sep22)
=33.782/53.849
=0.62734684

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep21)
=61.107/259.321
=0.23564231

Blum Holdings's asset turnover of this year was 0.62734684. Blum Holdings's asset turnover of last year was 0.23564231. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+0+0+1+0+1+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Blum Holdings has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Blum Holdings  (OTCPK:BLMH) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Blum Holdings Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Blum Holdings's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Blum Holdings (Blum Holdings) Business Description

Traded in Other Exchanges
N/A
Address
3242 South Halladay Street, Suite 202, Santa Ana, CA, USA, 92705
Blum Holdings Inc formerly Unrivaled Brands Inc is a vertically integrated cannabis multi-state operator having a cannabis brand spanning consumer products, cultivation, distribution, and retail. Its brands include Korova, Sticks, and Cabana, among others. It operates leading dispensaries throughout the state as well as several leading company-owned brands including Korova, known for its high potency products across multiple product categories.
Executives
Patty Chan officer: CHIEF FINANCIAL OFFICER 11516 DOWNEY AVE, DOWNEY CA 90241
Oren Schauble officer: President 3242 S HALLADAY ST., SUITE 202, SANTA ANA CA 92705
Dallas Imbimbo director 1800 NEWPORT CIRCLE, SANTA ANA CA 92705
Eric Baum director 866 BERKSHIRE DRIVE, WESTBURY NY 11590
Tiffany N. Davis director 11852 MANHATTAN CT., RANCHO CUCAMONGA CA 91730
Michael Nahass director 2040 MAIN STREET, SUITE 225, IRVINE CA 92614
Derek Peterson director, officer: President and CEO 2040 MAIN STREET, SUITE 225, IRVINE CA 92614
Alan David Gladstone other: Former Director of Issuer P.O BOX 9699, NEWPORT BEACH CA 92658
Uri Kenig officer: Chief Operating Officer 2040 MAIN ST., SUITE 225, IRVINE CA 92614
Ira E. Ritter director C/O RITTER PHARMACEUTICALS INC., 1801 CENTURY PARK EAST, SUITE 1820, LOS ANGELES CA 90096
Nicholas Kovacevich director 2618 SAN MIGUEL DRIVE, #480, NEWPORT BEACH CA 92660
Knuettel Ii Francis director 205 NEWBURY ST, SUITE 204, FRAMINGHAM MA 01701
Jeffrey Robert Batliner officer: Chief Financial Officer 2040 MAIN STREET, SUITE 225, IRVINE CA 92614
Megan Jimenez officer: Chief Financial Officer 2040 MAIN ST., SUITE 225, IRVINE CA 92614
Matthew Morgan director, officer: Chief Executive Officer 2040 MAIN STREET, SUITE 225, IRVINE CA 92614